-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
GSK2818713
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/1422484-32-9.gif)
| Category | HCV Protease |
| CAS | 1422484-32-9 |
| Description | GSK2818713 is a novel Hepatitis C NS5A replication complex inhibitor. |
Product Information
| Synonyms | CHEMBL4476378|GSK2818713|SCHEMBL14705113|BDBM50514770|HY-145335|CS-0371547 |
| Molecular Weight | 848.99 |
| Molecular Formula | C46H56N8O8 |
| Canonical SMILES | CC(C(C(=O)N1C2CCCC2CC1C3=NC=C(N3)C4=CC5=C6C=CC(=CC6=C5C=C4)C7=CN=C(N7)C8CC9CCCC9N8C(=O)C(C(C)OC)NC(=O)OC)NC(=O)OC)OC |
| Purity | ≥99% |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 1860 |
| Exact Mass | 848.42211077 |
| Target | HCV Protease |
| XLogP3-AA | 2.5 |
